The largest database of trusted experimental protocols

9 protocols using cephalothin

1

Cefotaxime MIC and Antimicrobial Susceptibility

Check if the same lab product or an alternative is used in the 5 most similar protocols
MIC test of cefotaxime was conducted with the 15 strains carrying blaCTX-M genes and one ESBL negative strain (KCJ852). MIC was determined using broth microdilution method according to CLSI guidelines (CLSI, 2018 ). KCJ1409 (Mir et al., 2016 (link)), an ESBL-producing E. coli isolated from human was included as a positive control and DH5α, a non-pathogenic E. coli was included as a negative control.
Antimicrobial susceptibility test (AST) was further performed on each representative strain (KCJ3819, KCJ3823, and KCJ3859) from CTX-M positive samples (n = 3) and one ESBL negative strain (KCJ852). The standard Kirby Bauer disk diffusion method on Mueller Hinton agar was used. The control strains used for the AST were E. coli (ATCC 35401), S. aureus (ATCC 25923) and Pseudomonas aeruginosa (ATCC 27853). The antimicrobial disks used are listed below: Amikacin (K; 30 μg), Ampicillin (A; 10 μg), Amoxycillin/Clavulanic acid (X; 30 μg), Sulfisoxazole (Z; 0.25 mg), Ceftiofur (R; 30 μg), Chloramphenicol (C; 30 μg), Cephalothin (F; 30 μg), Gentamicin (G; 10 μg), Nalidixic acid (N; 30 μg), Streptomycin (S; 10 μg), Sulfamethoxazole/trimethoprim (M; 23.75 μg/1.25 μg), and Tetracycline (T; 30 μg) (BD, United States).
+ Open protocol
+ Expand
2

Antimicrobial Resistance Profile of FQ-Resistant E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
All FQ-resistant E. coli isolates were investigated for their antimicrobial resistance with the disc diffusion test using the following discs (BD Biosciences): amoxicillin-clavulanate (20/10 μg), ampicillin (10 μg), cefazolin (30 μg), cephalothin (30 μg), cefadroxil (30 μg), cefoxitin (30 μg), chloramphenicol (30 μg), gentamicin (10 μg), imipenem (10 μg), nalidixic acid (30 μg), tetracycline (30 μg), and trimethoprim-sulfamethoxazole (1.25/23.75 μg). Minimum inhibitory concentrations (MICs) ranging from 0.06 to 512 mg/L to nalidixic acid, ciprofloxacin, and enrofloxacin (Sigma-Aldrich) were determined using standard agar dilution methods according to recommendations of the Clinical & Laboratory Standards Institute (CLSI, 2015 , 2020 ). E. coli ATCC 25922 was included as a quality control. Multidrug-resistance (MDR) was defined as acquired resistance to at least one agent in 3 or more antimicrobial classes (Magiorakos et al., 2012 (link)).
+ Open protocol
+ Expand
3

Antibiotic Resistance Evaluation of ESBL/AmpC E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antibiotic resistance of 59 ESBL/AmpC producing E. coli isolates was evaluated by minimum inhibitory concentration (MIC) of cefotaxime and antimicrobial susceptibility test (AST). MIC testing was performed using a micro-broth dilution method that followed the Clinical and Laboratory Standards Institute (CLSI) guidelines (CLSI, 2015 , 2016 ). The concentration of cefotaxime was serially diluted with Mueller Hinton Broth (MHB) from 0 to 256 μg/mL with the MIC defined by the highest concentration among three replicates. The ESBL-producing strain KCJ1409 was used as a positive control, and DH5α as a negative control (Mir et al., 2016 (link)). The standard Kirby Bauer disk diffusion method on Mueller Hinton Agar (MHA) was used to test susceptibility against the following 13 antibiotics: amikacin (30 μg), ampicillin (10 μg), amoxicillin/clavulanic acid (30 μg), sulfisoxazole (250 μg), ceftiofur (30 μg), chloramphenicol (30 μg), cephalothin (30 μg), gentamicin (10 μg), nalidixic acid (30 μg), streptomycin (10 μg), sulfamethoxazole/trimethoprim (23.75 μg/1.25 μg), tetracycline (30 μg), and colistin (10 μg) (BD, United States). E. coli (ATCC 35401), Staphylococcus aureus (ATCC 25923), and Pseudomonas aeruginosa (ATCC 27853) were used as controls.
+ Open protocol
+ Expand
4

Antimicrobial Susceptibility Testing of E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
An antimicrobial susceptibility test was performed using the disc diffusion method, according to the standards and interpretive criteria described by the Clinical and Laboratory Standards Institute (CLSI, 2017 ). The following antimicrobials were used (BD Biosciences): amoxicillin-clavulanate (20/10 μg), ampicillin (10 μg), cefadroxil (30 μg), cefazolin (30 μg), cefepime (30 μg), cefotaxime (30 μg), cefoxitin (30 μg), ceftazidime (30 μg), cefuroxime (30 μg), cephalexin (30 μg), cephalothin (30 μg), chloramphenicol (30 μg), ciprofloxacin (5 μg), gentamicin (10 μg), imipenem (10 μg), nalidixic acid (30 μg), tetracycline (30 μg), and trimethoprim-sulfamethoxazole (1.25/23.75 μg). The E. coli strain ATCC 25922 was used for quality control purposes.
+ Open protocol
+ Expand
5

Antimicrobial Resistance Profiling of cefE. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
All third-generation cephalosporin-resistant E. coli isolates were investigated for their antimicrobial resistance using the disc diffusion test with the following 19 discs (BD Biosciences): amikacin (30 μg), amoxicillin/clavulanate (20/10 μg), ampicillin (10 μg), cefazolin (30 μg), cefepime (30 μg), cefoxitin (30 μg), cephalothin (30 μg), chloramphenicol (30 μg), ciprofloxacin (5 μg), colistin (10 μg), doxycycline (30 μg), gentamicin (10 μg), kanamycin (30 μg), nalidixic acid (30 μg), neomycin (30 μg), norfloxacin (10 μg), streptomycin (10 μg), tetracycline (30 μg), and trimethoprim/sulfamethoxazole (1.25/23.75 μg). Results were interpreted according to the Clinical and Laboratory Standards Institute guidelines [15 , 16 ]. The minimum inhibitory concentrations (MICs) for cefazolin, cephalothin, cefoxitin, cefotaxime, cefpodoxime, ceftazidime, ceftriaxone, and cefepime were determined by standard broth microdilution methods with Mueller–Hinton broth (BD Biosciences) according to the recommendations of the CLSI [15 , 16 ]. Escherichia coli ATCC 25,922 strain was used the control organisms in the antimicrobial susceptibility tests. Multi-drug resistance (MDR) was defined as acquired non-susceptibility to at least 1 agent in 3 or more antimicrobial categories [17 (link)].
+ Open protocol
+ Expand
6

Antibiotic Resistance Screening in Environmental Isolates

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples were first plated on Chromocult agar, and then presumptive E. coli colonies were transferred onto MacConkey lactose (MKL) agar for confirmation before replating on Chromocult was performed to ensure pure isolates. We selected up to four E. coli colonies from soil and fecal samples and two from water and surface samples to test for AR. More isolates from soil samples than from water or surfaces were used because we expected higher microbial diversity in soil. Antibiotic sensitivity was assessed using the Kirby-Bauer disc diffusion method (43 (link)) and 12 antibiotics: ampicillin, amoxicillin/clavulanate, cefotaxime, cephalothin, chloramphenicol, ciprofloxacin, enrofloxacin, gentamicin, streptomycin, sulfisoxazole, trimethoprim-sulfamethoxazole, and tetracycline (Becton, Dickinson, Franklin Lakes, NJ). Zones of inhibition were measured after a 24-h incubation period using digital calipers.
+ Open protocol
+ Expand
7

Antibiotic Resistance Profiling of E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assess antibiotic resistance profiles of E. coli isolates, about every fifth of the enrichments prepared for the detection of Shiga toxin genes were selected (EE broth; 18–24 h, 37 °C). The enriched samples (one loopful: approx. 10 µl) were subcultured for 24 h at 37 °C on chromogenic RAPID’ E. coli 2 agar (Bio-Rad Laboratories, Reinach, Switzerland). One E. coli colony (violet to pink on RAPID’ E. coli 2 agar) from each of the 95 samples was selected and subjected to susceptibility testing against 12 antimicrobial agents by the disc diffusion method according to the Clinical and Laboratory Standards Institute (CLSI) protocols and criteria [8 ]. The panel included ampicillin (AM, 10 µg), amoxicillin-clavulanic acid (AMC, 30 µg), chloramphenicol (C, 30 µg), cephalothin (CF, 30 µg), ciprofloxacin (CIP, 5 µg), cefotaxime (CTX, 30 µg), gentamicin (GM, 10 µg), kanamycin (K, 30 µg), nalidixic acid (NA, 30 µg), streptomycin (S, 10 µg), tetracycline (TE, 30 µg), and trimethoprim (TMP, 5 µg) (Becton–Dickinson).
+ Open protocol
+ Expand
8

Antibiotic Resistance Testing of Vibrio

Check if the same lab product or an alternative is used in the 5 most similar protocols
The production of β-lactamase was tested using Cefinase disks (Becton, Dickinson and Company, Franklin Lakes, NJ, United States) according to the manufacturer’s instructions. Susceptibility to select β-lactam antibiotics was determined as described previously (Letchumanan et al., 2015 (link)). V. antiquarius 939 was grown overnight (18 h) on Mueller-Hinton agar plates (Becton, Dickinson and Company, Franklin Lakes, NJ, United States) (supplemented with 1.5% NaCl) at 37°C. Overnight growth was resuspended in a filter-sterilized 0.85% NaCl solution, normalized to approximate a 0.5 McFarland standard, and fresh Mueller-Hinton agar plates were seeded with a bacterial lawn using a sterile cotton swab. Penicillin (10 units), ampicillin (10 μg), cephalothin (30 μg), and carbenicillin (100 μg) antibiotic disks (Becton, Dickinson and Company, Franklin Lakes, NJ, United States) were dispensed on the lawn and plates were incubated overnight (18 h) at 37°C. The zones of inhibition were measured and interpreted according to the Clinical and Laboratory Standards Institute (CLSI) guidelines (Clinical and Laboratory Standards Institute [CLSI], 2010 ). The pandemic type strain of V. parahaemolyticus (RIMD2210633) (Nasu et al., 2000 (link)) was tested for comparative purposes.
+ Open protocol
+ Expand
9

Legionella Monitoring in Hospital Water

Check if the same lab product or an alternative is used in the 5 most similar protocols
Water was collected from 12 sink faucets in a hospital administrative and outpatient building, twice a week over 6.5 weeks for 13 sampling dates, for a total of 156 samples. The hot water outlets were opened, and 500 mL of the immediate water flow was collected into sterile bottles containing sodium thiosulfate to neutralize any residual chlorine in the water. The samples were cultured using a modified ISO method [21 ] immediately on site (T0), then again at 1 h (T1), 24 h (T24), and 48 h (T48) from collection for a total of 624 cultures. Water samples were held at room temperature throughout the testing period. On site at T0, 0.1 mL aliquots of each sample were plated onto two selective agar media: DGVP and BCYE with colistin, cephalothin, vancomycin, and cycloheximide (CCVC) (Becton, Dickinson, and Company, Franklin Lakes, NJ, USA). Upon returning to the laboratory, the T0 agar plates were placed into a humidified incubator at 36.5 ± 1 °C. After holding times of 1 h, 24 h, and 48 h (T1, T24, and T48), each water sample was plated directly and after filter concentration (100 mL was concentrated as above) onto BCYE and to DGVP agar plates. If the initial culture plates were overgrown, the filter concentrates were re-plated after pre-treatment with acid (0.2 M KCl, pH 2.2 ± 1). All sets of cultures were incubated for 7 days and examined for Legionella as above.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!